PT-141 (10mg)

Description

PT-141 (Bremelanotide) is a synthetic cyclic heptapeptide melanocortin receptor agonist derived from Melanotan 2, with primary activity at MC3R and MC4R receptors. This 10mg lyophilized preparation is manufactured to ≥99% purity and verified by third-party HPLC analysis.

Studied in research models for its melanocortin receptor-mediated effects on central nervous system signaling pathways, PT-141 is utilized in protocols investigating MC4R pharmacology, hypothalamic signaling, and melanocortin receptor subtype selectivity. Supplied as a sterile lyophilized powder for reconstitution.

For research use only. Not for human consumption.